TickerFactsScreenerDevelopers

AbbVie Inc. (ABBV) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2010: $10.00M2011: $27.00M2012: $5.90B2013: $9.60B2014: $8.35B2015: $8.40B2016: $5.10B2017: $9.30B2018: $7.29B2019: $39.92B2020: $8.45B2021: $9.75B2022: $9.20B2023: $12.81B2024: $5.52B2025: $5.23B$5.23B
2010Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$5.23B-5.3%
2024$5.52B-56.9%
2023$12.81B+39.3%
2022$9.20B-5.6%
2021$9.75B+15.4%
2020$8.45B-78.8%
2019$39.92B+447.7%
2018$7.29B-21.6%
2017$9.30B+82.4%
2016$5.10B-39.3%
2015$8.40B+0.6%
2014$8.35B-13.0%
2013$9.60B+62.6%
2012$5.90B+21755.6%
2011$27.00M+170.0%
2010$10.00M—